Ensifentrine, a dual PDE3/PDE4 inhibitor, improves FEV1 regardless of smoking status or history of chronic bronchitis

T. Rheault (London, United Kingdom), T. Bengtsson (Lund, Sweden), K. Rickard (London, United Kingdom)

Source: Virtual Congress 2020 – Cutting edge science: novel molecules and mechanisms of airway diseases
Session: Cutting edge science: novel molecules and mechanisms of airway diseases
Session type: Oral Presentation
Number: 4786

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Rheault (London, United Kingdom), T. Bengtsson (Lund, Sweden), K. Rickard (London, United Kingdom). Ensifentrine, a dual PDE3/PDE4 inhibitor, improves FEV1 regardless of smoking status or history of chronic bronchitis. 4786

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: